The Cancer Consortium Survivorship Pilot Award 2026 offers up to US$50,000 for one year to help researchers test new ideas about cancer survivorship. The award is offered through the Fred Hutch, University of Washington and Seattle Children’s Cancer Consortium.
Projects may examine follow-up care, late effects of treatment or quality of life. Health services research is eligible, and preliminary data are optional. Studies focused on diagnosis or active treatment must link that period to a long-term health or psychosocial outcome.
Eligibility and Selection Criteria
- At least one principal investigator should be a Cancer Consortium investigator.
- Proposals must focus on cancer survivorship and describe work that can be completed in one year.
- A team member must pitch the proposal at the Late Effects & Survivorship Affinity Group seminar on January 14, 2027.
- The consortium prioritises collaborations across its partner institutions and new collaborations within a partner institution.
- Investigators who have not previously received a Survivorship Pilot Award receive priority.
- If ethics approval is required, teams must provide evidence of approval before receiving funds.
Funding Details
- Maximum award: US$50,000 in direct costs over one year.
- Eligible costs: Salaries, supplies and shared research resources.
- Excluded costs: Indirect costs and subawards.
Deadline
- Application deadline: December 15, 2026.
- Proposal pitch: January 14, 2027.
- Award notifications: By February 1, 2027.
- Funding starts: June 1, 2027.
Further Information
- Official call and application instructions
- Submission: Email the application as a single PDF to Emily Artim. Include the lead investigator’s last name and a shortened project title in the filename.
- Programme enquiries: Dr. Eric Chow